Barbiturates for the treatment of intracranial hypertension after traumatic brain injury
- PMID: 18983702
- PMCID: PMC2592754
- DOI: 10.1186/cc7020
Barbiturates for the treatment of intracranial hypertension after traumatic brain injury
Abstract
In their article on the use of barbiturates for the treatment of intracranial hypertension after traumatic brain injury, Perez-Barcena and colleagues conclude that thiopental was more effective than pentobarbital in decreasing intracranial pressure. Here we discuss the limitations of this study and review areas of controversy surrounding barbiturate use in neurocritical care.
Comment on
-
Pentobarbital versus thiopental in the treatment of refractory intracranial hypertension in patients with traumatic brain injury: a randomized controlled trial.Crit Care. 2008;12(4):R112. doi: 10.1186/cc6999. Epub 2008 Aug 29. Crit Care. 2008. PMID: 18759980 Free PMC article. Clinical Trial.
References
-
- Pérez-Bárcena J, Llompart-Pou JA, Homar J, Abadal JM, Raurich JM, Frontera G, Brell M, Ibanez J, Ibanez J. Pentobarbital versus thiopental in the treatment of refractory intracranial hypertension in patients with traumatic brain injury: a randomized controlled trial. Crit Care. 2009;12:R112. doi: 10.1186/cc6999. - DOI - PMC - PubMed
-
- Timbrell J. Principles of Biochemical Toxicology. Philadelphia, PA: Taylor & Francis; 2000.
-
- Warner DS, Takaoka S, Wu B, Ludwig PS, Pearlstein RD, Brinkhous AD, Dexter F. Electroencephalographic burst suppression is not required to elicit maximal neuroprotection from pentobarbital in a rat model of focal cerebral ischemia. Anesthesiology. 1996;84:1475–1484. doi: 10.1097/00000542-199606000-00024. - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
